Novel epidemiologic and mechanistic aspects of the metabolic syndrome

Detta är en avhandling från Stockholm : Karolinska Institutet, Department of Medicine

Sammanfattning: Introduction The metabolic syndrome is a cluster of cardiometabolic risk factors that increase risk of developing cardiovascular disease. Its prevalence continues to rise worldwide and it is becoming a public health burden. The aim of my thesis was to help elucidate some of the epidemiologic and mechanistic aspects behind the metabolic syndrome. Material and Methods For paper I the National Health and Nutrition Examination Survey (NHANES) III was used. For paper II the NHANES III Mortality study was used with follow-up mortality on NHANES III subjects. For paper III, the 60 year old Stockholm county cohort, the Swedish Diet and metabolic syndrome (KOMET) study and the NHANES 2005-06 cohorts were used. For paper IV, the 65 year old Stockholm County physical activity intervention study was used. Results Paper I showed that the apolipoproteinB/apolipoproteinAI (apoB/apoAI) ratio is strongly associated with insulin resistance beyond the association explained by traditional risk factors, metabolic syndrome components, and inflammatory risk factors. Paper II showed that apolipoprotein measurements significantly predict coronary heart disease (CHD) death, independently of cardiovascular (CV) risk factors and that this predicting ability was better than any of the routine clinical lipid measurements. Paper III showed that gamma glutamyl transferase (GGT) is significantly associated with the metabolic syndrome in elderly asymptomatic subjects and that this association seems to be mediated, at least in part by C-reactive protein (CRP). Paper IV showed that change in adipose tissue gene expression is associated with changes in metabolic syndrome parameters. Furthermore, lifestyle modification can influence changes in adipose tissue gene expression, which may in turn modulate metabolic syndrome parameters. Conclusions ApoB/apoAI ratio is a marker of insulin resistance. Apolipoprotein B should be included in guidelines assessing cardiometabolic risk. GGT relationship to the metabolic syndrome seems to be mediated, at least in part, by changes in CRP. Changes in parameters of the metabolic syndrome seem to be mediated, at least in part, by changes in adipose tissue gene expression after increased physical activity.

  HÄR KAN DU HÄMTA AVHANDLINGEN I FULLTEXT. (följ länken till nästa sida)